This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Pfizer Inc. (PFE) rose 1.30% to $25.66 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
Pfizer Inc. closed 10.73% short of its 52-week high of $28.75, which the company achieved on April 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 0.47% to $230.00, Eli Lilly &amp; Co. (LLY) rose 3.37% to $1,021.41, and Abbott Laboratories (ABT) rose 1.04% to $88.82.
Trading volume (40.9 M) eclipsed its 50-day average volume of 37.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-19-26 1636ET

Pfizer Inc. (PFE) shares rose 1.30% to $25.66 on a challenging trading day for the market, outperforming competitors like Johnson & Johnson and Eli Lilly. Despite the gain, Pfizer remains 10.73% below its 52-week high of $28.75. The trading volume reached 40.9 million, surpassing its 50-day average of 37.8 million.

- Shares of Pfizer Inc. (PFE) increased by 1.30% to $25.66 amid a generally negative trading day for the stock market.  
- The stock remains 10.73% below its 52-week high of $28.75, reached on April 2nd, while competitors like Johnson & Johnson and Eli Lilly saw gains.  
- Trading volume for Pfizer was 40.9 million, surpassing its 50-day average of 37.8 million.

MarketWatch Automated

Pfizer

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Direxion S&P Biotech Bull 3X

Ark Genomic Revolution ETF

iShares US Pharma

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

iShares Biotechnology ETF

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Eli Lilly

Abbott Laboratories

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day